Keio University group finds culture conditions to produce highly pure iPS-derived human cardiomyocytes

In this study financed by AMED the trick was to substitute glutamate and glucose in the iPS culture medium. In such case, the ratio of residual undifferentiated iPS cells in the expanded cardiomyocytes intended for transplantation was less than 0.001 %. Clinical studies based on this finding were already announced.

China Bio news release, June 15, 2016

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny